According to Appili Therapeutics latest financial reports the cash on hand of APLI is $1.83M, an decrease of -63.00% to 2022. At the end of 2022 company had $4.94M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.83M | -63.00% |
2022 | $4.94M | -58.67% |
2021 | $11.95M | 52.98% |
2020 | $7.81M | 93.34% |
2019 | $4.04M | - |